Platte River Wealth Advisors, LLC Eli Lilly & CO Transaction History

Platte River Wealth Advisors, LLC

$378 Million
Q3 2024

A detailed history of Platte River Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Platte River Wealth Advisors, LLC holds 8,272 shares of LLY stock, worth $6.18 Million. This represents 1.94% of its overall portfolio holdings.

Number of Shares

8,272

Previous 8,272 -0.0%

Holding current value

$6.18 Million

Previous $7.49 Million 2.15%

% of portfolio

1.94%

Previous 2.1%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$724.87 - $909.04 $143,524 - $179,989	-198 Reduced 2.34%	8,272 $7.49 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $145,089 - $194,108	-245 Reduced 2.81%	8,470 $6.59 Million
Q4 2023 Jan 12, 2024	SELL	$525.19 - $619.13 $59,346 - $69,961	-113 Reduced 1.28%	8,715 $5.08 Million
Q3 2023 Oct 11, 2023	SELL	$434.7 - $599.3 $22,604 - $31,163	-52 Reduced 0.59%	8,828 $4.74 Million
Q2 2023 Jul 07, 2023	SELL	$350.74 - $468.98 $131,527 - $175,867	-375 Reduced 4.05%	8,880 $4.16 Million
Q1 2023 Apr 07, 2023	SELL	$310.63 - $364.82 $46,594 - $54,723	-150 Reduced 1.59%	9,255 $3.18 Million
Q3 2022 Oct 21, 2022	BUY	$296.48 - $337.87 $11,859 - $13,514	40 Added 0.43%	9,405 $3.04 Million
Q2 2022 Jul 08, 2022	BUY	$278.73 - $327.27 $85,012 - $99,817	305 Added 3.37%	9,365 $3.04 Million
Q1 2022 Apr 19, 2022	SELL	$234.69 - $291.66 $105,610 - $131,247	-450 Reduced 4.73%	9,060 $2.6 Million
Q4 2021 Jan 12, 2022	BUY	$224.85 - $279.04 $101,182 - $125,568	450 Added 4.97%	9,510 $2.5 Million
Q3 2021 Oct 20, 2021	BUY	$221.6 - $272.71 $44,320 - $54,541	200 Added 2.26%	9,060 $2.09 Million
Q2 2021 Jul 15, 2021	BUY	$180.55 - $233.54 $37,012 - $47,875	205 Added 2.37%	8,860 $2.03 Million
Q1 2021 Apr 12, 2021	BUY	$164.32 - $212.72 $133,920 - $173,366	815 Added 10.4%	8,655 $1.58 Million
Q4 2020 Jan 22, 2021	SELL	$130.46 - $172.63 $84,146 - $111,346	-645 Reduced 7.6%	7,840 $1.59 Million
Q3 2020 Nov 04, 2020	BUY	$146.22 - $169.13 $161,573 - $186,888	1,105 Added 14.97%	8,485 $1.26 Million
Q2 2020 Jul 07, 2020	SELL	$136.42 - $164.18 $33,422 - $40,224	-245 Reduced 3.21%	7,380 $1.23 Million
Q4 2019 Feb 03, 2020	BUY	$106.92 - $132.43 $815,265 - $1.01 Million	7,625 New	7,625 $1.07 Million

Others Institutions Holding LLY

# of Institutions

4,389

Shares Held

821M

Call Options Held

10M

Put Options Held

10.8M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $710B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Platte River Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Platte River Wealth Advisors, LLC with notifications on news.

Account

Platte River Wealth Advisors, LLC Eli Lilly & CO Transaction History